Author: admin

Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!

As investors search for “stocks under $5 to buy now,” “small-cap growth stocks 2026,” “AI healthcare stocks,” “quantum computing stocks,” and “emerging Nasdaq breakout stocks,” several under-the-radar companies are drawing increased attention across financial media platforms and AI-driven discovery engines including Google AI, Grok, Meta AI, ChatGPT, Microsoft Copilot, and Perplexity AI.

Here’s a forward-looking look at five Nasdaq-listed names positioned across high-growth sectors:

Larimar Therapeutics, Inc. (Nasdaq: LRMR)

Rare Disease Biotech Catalyst Play

Larimar Therapeutics continues to advance its clinical-stage pipeline targeting complex rare diseases. As investor interest in “orphan drug stocks” and “rare disease biotech catalysts” increases, LRMR remains on watchlists for potential regulatory and clinical milestones. With biotech volatility creating trading opportunities, investors are closely monitoring development updates, FDA pathway progress, and partnership potential that could unlock long-term value.

Recursion (Nasdaq: RXRX)

AI-Powered Drug Discovery Platform

Recursion operates at the intersection of artificial intelligence, machine learning, and drug discovery. As investors increasingly look for “AI biotech stocks” and “machine learning pharmaceutical companies,” RXRX stands out with its data-driven platform aimed at accelerating therapeutic development. Strategic collaborations, computational biology advancements, and pipeline updates continue to support long-term growth narratives in AI-enabled healthcare.

ENDRA Life Sciences (Nasdaq: NDRA)

AI-Driven Liver Imaging and Non-Invasive Diagnostics

ENDRA Life Sciences is positioning its Thermo-Acoustic Enhanced UltraSound (TAEUS®) technology as a non-invasive solution for liver disease assessment. As the global market searches for “AI medical imaging stocks” and “non-invasive diagnostic companies,” NDRA represents exposure to a rapidly expanding metabolic and liver health market. Continued commercialization initiatives and regulatory progress could serve as inflection points in 2026.

BTQ Technologies Corp. (Nasdaq: BTQ)

Quantum Infrastructure & QCIM Acceleration

BTQ Technologies is a vertically integrated quantum company driving the shift from classical networks to the quantum internet. Backed by a broad patent portfolio, BTQ delivers a full-stack neutral-atom quantum computing platform spanning hardware, middleware, and post-quantum security solutions.

The company recently announced a New York City Quantum Hardware Commercialization Hub and key engineering hires to accelerate its Quantum Compute in Memory (QCIM) roadmap, strengthening its push toward enterprise and government deployment across finance, telecom, logistics, life sciences, and defense.

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO)

AI-Driven Heart Disease Detection

Cardio Diagnostics is a precision medicine company using artificial intelligence and epigenetics to improve early detection of heart disease. Its blood-based diagnostic tests aim to identify cardiovascular risk before major cardiac events occur.

As investors search for “AI healthcare stocks,” “cardiovascular diagnostics companies,” and “precision medicine growth stocks,” CDIO represents exposure to the expanding market for predictive, non-invasive heart health solutions heading into 2026.

The Bigger Picture

From rare disease biotechnology and AI-powered drug discovery to quantum-secure silicon and digital media monetization, LRMR, NDRA, RXRX, BTQ, and CDIO represent diversified exposure to high-growth industries trading under $5.

With increased retail investor participation, algorithmic screening for “low-priced Nasdaq stocks,” and AI-powered search discovery amplifying visibility, these companies are gaining traction across watchlists as potential 2026 breakout candidates.

As always, small-cap investing involves elevated volatility and risk, but for investors scanning the market for “emerging growth stocks under $5,” this group is firmly on the radar.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!

Stocks Under $1 XWEL, TOON, KIDZ, HCWC to Watch Now – More Co’s Inside

As investors search for “stocks under $1 to buy now,” “small-cap breakout stocks 2026,” “AI education stocks,” “wellness growth stocks,” “organic grocery expansion,” and “microcap acquisition targets,” several emerging companies across Nasdaq, NYSE American, and OTC markets are generating renewed attention.

Below is a forward-looking look at small-cap stocks positioned around capital raises, AI integration, revenue growth, and strategic partnerships.

XWELL, Inc. (Nasdaq: XWEL) is a global wellness company delivering science-backed services across travel, retail, and clinical environments through brands such as XpresSpa®, Naples Wax Center®, and XpresCheck®.

The company recently entered into a securities purchase agreement expected to generate approximately $31.3 million in gross proceeds via private placement financing. For investors screening “wellness stocks under $1” or “travel retail recovery plays,” this capital infusion could provide operational flexibility, balance sheet strengthening, and expansion opportunities.

With wellness demand accelerating globally and airport traffic normalizing, XWEL is positioning itself at the intersection of preventative health, beauty services, and diagnostic solutions.

Kartoon Studios (NYSE: TOON) continues to gain visibility ahead of its Q4 and full-year financial results. The company’s CFO recently discussed Q3 performance and 2026 expectations on “The Street Podcast,”highlighting media ecosystem growth amid an evolving streaming landscape.

With ongoing industry consolidation involving major players like Netflix and Warner Bros. Discovery, smaller content owners are increasingly viewed as potential acquisition or partnership candidates.

For investors searching “media stocks under $1,” “animation studio acquisition targets,” or “children’s content streaming plays,” TOON remains a speculative watchlist name heading into earnings.

Classover Holdings Inc. (NASDAQ: KIDZ) reshaping K-12 digital education through AI-powered learning systems built on more than 420,000 hours of live teaching experience. Its newly published white paper, “The Delivery Problem,” outlines how Tutor Studio’s AI-driven micro-learning architecture has reportedly increased instructional productivity by 200%, effectively doubling teaching capacity without proportional staffing growth.

For investors searching “AI education stocks,” “EdTech stocks under $1,” or “blockchain education platforms,” KIDZ represents exposure to scalable AI-orchestrated academic infrastructure as global demand for measurable, verifiable remote learning increases.

Healthy Choice Wellness Corp. (NYSE: HCWC) reported record fiscal 2025 results, including:

  • $78 million in annual revenue (13% YoY growth)
  • $30 million gross profit
  • 39% full-year gross margin
  • Operations across 19 natural and organic grocery locations in six states

For investors searching “organic grocery growth stocks,” “natural food retail expansion,” or “health-conscious consumer trends 2026,” HCWC’s operational scale and margin expansion highlight improving fundamentals within the natural foods sector.

Special OTC Companies to Watch Now

Beyond exchange-listed names, several OTC companies are drawing attention among microcap investors searching for “OTC breakout stocks,” “critical minerals plays,” “gold stocks under $1,” and “blockchain infrastructure penny stocks.

– American Lithium Materials, Inc. (OTC: AMLM) – Gold, Silver, Copper Critical Minerals, PGM’s REE’s Lithium, etc

· Nightfood Holdings, Inc. (OTCQB: NGTF) – Consumer wellness & hospitality focus

· Brookmount Gold (OTC: BMXI) – Precious metals development

· Renewal Fuels Inc (OTC: RNWF) – Renewable fuels strategy

· Clifton Mining (OTC: CFTN) – Gold & silver production interests

· Dateline Resources Ltd (OTCQB: DTREF) – Mineral exploration

· ADM Endeavors (OTCQB: ADMQ) – Apparel & promotional products growth

· Full Alliance Group (OTC: FAGI) – Digital infrastructure & tokenized engagement platforms

Full Alliance Group (OTC: FAGI) in particular has advanced its blockchain infrastructure strategy, positioning itself within the digital asset custody and tokenization ecosystem — a segment increasingly searched under “RWA tokenization stocks,” “digital securities platforms,” and “microcap blockchain infrastructure.”

Market Outlook

As 2026 unfolds, investors scanning for “best penny stocks now,” “stocks under $1 with catalysts,” and “small-cap growth opportunities” are closely monitoring capital raises, AI integration, margin expansion, and acquisition positioning.

While small-cap and microcap stocks carry elevated volatility and risk, the combination of fresh capital, operational growth, and thematic exposure across wellness, AI education, media, natural foods, mining, renewable energy, and blockchain infrastructure continues to attract speculative capital.

Investors should conduct independent due diligence and evaluate risk tolerance carefully before considering positions in small-cap or OTC securities.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Stocks Under $1 XWEL, TOON, KIDZ, HCWC to Watch Now – More Co’s Inside

Microcap Stocks: AMLM, NGTF, BMXI, FAGI, RNWF Gaining Momentum – More Inside

As investors increasingly search for “OTC breakout stocks,” “gold stocks under $1,” “critical minerals penny stocks,” “renewable energy microcaps,” and “blockchain infrastructure stocks,” a select group of OTC-listed companies is drawing speculative interest heading into 2026.

Below is a forward-looking look at eight OTC companies operating across critical minerals, precious metals, consumer wellness, renewable fuels, apparel manufacturing, mineral exploration, and digital asset infrastructure.

American Lithium Materials, Inc. (OTC: AMLM)

American Lithium Materials is positioning itself as a diversified critical minerals exploration company with exposure to gold, silver, copper, lithium, platinum group metals (PGMs), and rare earth elements (REEs).

As global governments prioritize domestic sourcing of battery metals and defense-related minerals, With electrification, AI data centers, and EV production fueling commodity demand, multi-commodity explorers like AMLM are increasingly viewed as leveraged plays on the broader energy transition and infrastructure cycle.

Nightfood Holdings, Inc. (OTCQB: NGTF)

Nightfood Holdings operates within the consumer wellness and hospitality sector, capitalizing on growing demand for better-for-you food products and hospitality-focused consumer experiences.

As investors scan for “consumer wellness stocks,” “health-focused food brands,” and “hospitality turnaround plays,” NGTF represents a microcap positioned at the intersection of health-conscious consumer trends and travel recovery dynamics.

Brookmount Gold (OTC: BMXI)

Brookmount Gold provides exposure to the strengthening precious metals narrative. With gold maintaining resilience amid inflation concerns, central bank accumulation, and geopolitical risk, BMXI fits within popular searches for “gold mining stocks under $1” and “junior gold producers.”

As gold and silver markets remain volatile but structurally supported, junior producers and development-stage companies often attract speculative capital during bullish commodity cycles.

Renewal Fuels Inc (OTC: RNWF)

Renewal Fuels is aligned with the renewable fuels and alternative energy segment. With governments continuing to push carbon-reduction initiatives and energy diversification, RNWF may benefit from search momentum around “renewable fuel stocks,” “biofuel penny stocks,” and “clean energy microcaps.”

Full Alliance Group (OTC: FAGI)

Full Alliance Group has advanced its blockchain infrastructure strategy, positioning itself within the digital asset custody and tokenization ecosystem.

With rising investor interest in “RWA tokenization stocks,” “digital securities platforms,” “blockchain infrastructure penny stocks,” and “microcap crypto plays,” FAGI is targeting an emerging niche centered on tokenized engagement programs and enterprise digital asset architecture.

As real-world asset tokenization gains institutional attention globally, early-stage infrastructure participants could attract speculative interest.

ADM Endeavors (OTCQB: ADMQ)

ADM Endeavors operates in the apparel and promotional products sector. As small businesses and organizations expand branding efforts, ADMQ fits within search categories like “small-cap manufacturing stocks” and “apparel growth microcaps.”

Clifton Mining (OTC: CFTN)

Clifton Mining maintains interests in gold and silver production assets, offering additional exposure to the precious metals sector. For investors monitoring “silver stocks to watch” and “small-cap gold producers,” CFTN represents another microcap tied to commodity price movements.

Dateline Resources Ltd (OTCQB: DTREF)

Dateline Resources focuses on mineral exploration and development. As demand grows for diversified mining exposure, DTREF aligns with searches for “exploration mining stocks OTC” and “junior resource companies.”

Market Outlook for OTC Microcaps

While OTC stocks inherently carry higher volatility and liquidity risk, thematic alignment with high-growth sectors — including critical minerals, renewable energy, gold and silver, consumer wellness, and blockchain infrastructure — continues to drive online search interest and microcap trading activity.

Investors evaluating “best OTC stocks now” and “penny stocks with catalysts” are closely monitoring companies with commodity leverage, emerging digital platforms, or sector-specific growth narratives.

As always, microcap investing involves elevated risk, and independent due diligence remains essential before considering any position.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Microcap Stocks: AMLM, NGTF, BMXI, FAGI, RNWF Gaining Momentum – More Inside

LifeWellMD unveils 2026 men’s performance and longevity lab in Palm Beach and Port St. Lucie

“At LifeWellMD, our Men’s Performance and Longevity Lab is designed to help men stay strong, sharp and active for decades, using careful diagnostics and evidence-based, physician-guided care,” said Dr. Ramesh Kumar, founder of LifeWellMD.”
LifeWellMD, a physician-led integrative clinic, announces a 2026 Men’s Performance and Longevity Lab in North Palm Beach and Port St. Lucie, offering comprehensive, preventive men’s health and wellness programs for busy professionals.

North Palm Beach, FL – February 20, 2026 – LifeWellMD, a physician-led integrative medical clinic, today announced the launch of its 2026 Men’s Performance and Longevity Lab serving men in North Palm Beach, Port St. Lucie, and surrounding communities. The lab focuses on early detection of health risks and comprehensive, preventive care so that men can maintain energy, strength, and mental clarity as they age.

The new Men’s Performance and Longevity Lab brings together advanced assessments, individualized care plans, and ongoing monitoring under one roof. Men can receive detailed evaluations of cardiometabolic health, body composition, fitness capacity, hormone status, and lifestyle factors in a single, coordinated visit. Each assessment is followed by a tailored roadmap that may include nutrition guidance, exercise planning, sleep optimization, stress management strategies, and physician-guided therapeutic options when appropriate.

“Too many men wait until they feel unwell before seeking help,” said Dr. Ramesh Kumar, founder of LifeWellMD and a board-certified physician with decades of clinical experience. “Our goal is to change that pattern by making it easy and comfortable for men to get objective data, understand their risks, and take proactive steps with a trusted medical team by their side.”

Unlike symptom-focused clinics, LifeWellMD’s Men’s Performance and Longevity Lab emphasizes long-term health outcomes and continuous follow-up. Patients participate in structured programs that track progress over time, with regular check-ins, updated lab work when needed, and adjustments to their plan based on results. This approach is designed to support sustainable improvements in weight management, cardiovascular health, musculoskeletal resilience, and overall day-to-day performance at work and at home.

The lab also reflects LifeWellMD’s commitment to integrative and regenerative medicine. Under physician supervision, appropriate candidates may access therapies that support recovery, tissue health, and healthy aging as part of a broader, evidence-based treatment strategy. Every intervention is selected to align with current medical guidelines, individualized risk profiles, and the patient’s personal goals.

With locations in North Palm Beach and Port St. Lucie, LifeWellMD is positioned to serve professionals, entrepreneurs, and active adults across Palm Beach and the Treasure Coast who are seeking a structured, data-driven approach to long-term health. Appointments for the Men’s Performance and Longevity Lab are now available by phone for both new and existing patients.

About LifeWellMD:

LifeWellMD is an integrative, physician-led medical clinic with offices in North Palm Beach and Port St. Lucie, Florida, dedicated to helping adults optimize health, prevent disease, and improve quality of life through personalized, evidence-based care. The clinic offers comprehensive men’s and women’s health evaluations, hormone and metabolic assessments, lifestyle medicine programs, and regenerative therapies under medical supervision.

Media contact: LifeWellMD North Palm Beach and Port St. Lucie, Florida Phone: 561-210-9999 Email: drkumar@lifewellmd.com

Media Contact
Company Name: lifewellmd.com
Contact Person: Ramesh Kumar, MD
Email: Send Email
Phone: 7722537683
Address:1201 US 1, Suite 23B
City: North Palm Beach
State: FL
Country: United States
Website: https://lifewellmd.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: LifeWellMD unveils 2026 men’s performance and longevity lab in Palm Beach and Port St. Lucie

Empathy in Medicine Initiative Launches Student Chapter Program to Advance Human-Centered Communication in Healthcare

The Empathy in Medicine Initiative (EMI), a student-led nonprofit organization dedicated to strengthening empathy and communication in healthcare, has officially launched its Student Chapter Program for high school and college students. The new program provides a structured pathway for students to build empathy-focused clubs and initiatives using practical toolkits, templates, and scripts designed to create measurable community impact and promote patient-centered communication.

Founded by Kevin Lin, a student at Great Neck South High School in Great Neck, New York, EMI was established on the belief that empathy in healthcare should not require extensive training programs or sweeping curriculum changes. Instead, small, practical tools can meaningfully improve patient care and clinician well-being. With the launch of its Student Chapter Program, EMI is extending that philosophy to the next generation of aspiring healthcare leaders.

The Student Chapter Program enables high school and college students to start official EMI chapters or clubs in their schools and communities. These chapters are designed to run empathy-centered initiatives such as communication skills workshops, empathy-focused events and activities, and community education or service projects tied directly to patient-centered communication. The program offers students a clear structure, ensuring that their efforts are organized, ethical, and capable of producing measurable outcomes.

“Too many students want to do meaningful healthcare-related service and leadership, but they do not have a clear structure to start,” said Kevin Lin, founder of the Empathy in Medicine Initiative and a student at Great Neck South High School in Great Neck, New York. “Our chapter program gives high school and college students a practical toolkit to launch empathy-focused clubs and projects that create measurable impact in their schools and communities.”

The chapter program reflects EMI’s broader mission: to promote human-centered care and help patients feel heard, understood, and respected in every medical encounter. EMI provides ready-to-use communication tools, including empathy scripts, teach-back prompts, and agenda-setting cards, that clinicians can use immediately to build trust, reduce patient anxiety, and improve understanding without requiring extensive training programs.

Through the Student Chapter Program, these principles are translated into student-led initiatives. Chapters may host workshops that teach foundational communication strategies, organize events that highlight the role of empathy in healthcare settings, or develop service projects that educate communities about patient-centered communication practices. Each chapter operates with access to structured resources that make launching and sustaining activities manageable for busy students.

Among the key resources included in the program are practical toolkits and templates, such as meeting and event guides, communication scripts, and training materials. EMI has designed these materials to be accessible and straightforward, helping students focus on impact rather than administrative complexity. The templates provide a step-by-step roadmap for planning events, facilitating discussions, and implementing initiatives aligned with EMI’s core mission.

Early traction suggests strong demand for the structured model. EMI’s platform currently shows 233 users and 73 applications, with 69 applications pending or under review. This early engagement indicates that students are actively seeking a credible, organized framework to pursue leadership and service opportunities connected to healthcare communication.

The Student Chapter Program primarily targets high-achieving high school and college students, including those interested in pre-medical or other health-related pathways. It also serves student organization founders and officers who want to create mission-driven clubs with a clear purpose. Teachers and advisors who sponsor student groups represent a secondary audience, as EMI chapters can operate effectively with faculty mentorship.

While EMI is based in Great Neck, New York, and focuses on the Northeast and the broader New York City metro region, its online resources are accessible globally. Students across the United States and beyond can access materials, apply to start a chapter, and implement programs within their own schools and communities.

The initiative’s design emphasizes practicality. EMI’s tools are intended to fit into real-world workflows without adding unnecessary burden. Its toolkit includes downloadable PDFs such as printable cards, pocket references, and low-ink versions; copy-and-paste scripts suitable for electronic health record templates; and setting-specific implementation kits tailored for primary care, emergency departments, pediatrics, and telehealth. Micro-training modules are also available.

All materials are developed to integrate seamlessly into typical 15-minute appointments without extending visit length, reinforcing the principle that empathy can be embedded into routine practice.

In addition to its focus on practicality, EMI prioritizes privacy and clinical safety. The organization’s tools are designed for local use and do not collect patient data. EMI collects only anonymous, organization-level usage statistics, such as the number of toolkits downloaded by a given institution. No patient names, medical record numbers, or health information are collected, stored, or transmitted through the platform. All tools are intended to support communication, not clinical decision-making, and organizations are responsible for ensuring local compliance with relevant regulations.

By incorporating these safeguards, EMI seeks to provide a responsible and ethical framework for both clinical settings and student-led activities. The Student Chapter Program aligns with these principles, offering students a structured and privacy-conscious way to engage in healthcare-related leadership and service.

The launch of the chapter program addresses a growing interest among students in building meaningful extracurricular experiences connected to medicine and healthcare. Many students aspire to pursue healthcare careers and recognize the importance of empathy and communication, yet lack clear guidance on how to turn those values into organized, measurable initiatives. EMI’s structured model aims to fill that gap.

Through defined project guidelines, ready-to-use materials, and an application process, the program provides a transparent pathway from interest to action. Students can apply to start a chapter, receive resources, and begin implementing initiatives that reflect EMI’s mission of advancing human-centered care.

In doing so, EMI positions empathy not as an abstract ideal but as a practical skill set that can be developed and applied. Workshops may include role-play exercises using communication scripts, discussions on reducing patient anxiety, or community education sessions on effective patient-provider dialogue. These activities are designed to cultivate leadership while reinforcing the real-world relevance of communication in healthcare.

As EMI continues to expand its platform and review applications, the organization remains focused on building a sustainable network of student chapters committed to ethical service and measurable impact. The combination of structured resources, early user engagement, and a clear mission underscores the initiative’s commitment to credibility and practicality.

Students, educators, and advisors interested in learning more about the Student Chapter Program, accessing resources, or starting a chapter are encouraged to visit https://empathyinmedicine.org/.

Additional information about resources can be found at https://empathyinmedicine.org/Resources

Applications can be submitted at https://empathyinmedicine.org/apply.

EMI also shares updates through its Instagram page at https://www.instagram.com/empathyinmedicine.2026/.

About Empathy in Medicine Initiative (EMI)

Empathy in Medicine Initiative (EMI) is a student-led nonprofit organization based in Great Neck, New York, focused on advancing empathy and communication in healthcare. EMI’s mission is to promote human-centered care by providing ready-to-use communication tools that help patients feel heard, understood, and respected. The organization offers practical resources, including empathy scripts, teach-back prompts, agenda-setting cards, downloadable toolkits, and micro-training modules, designed to integrate seamlessly into real clinical workflows without collecting patient data. Through its new Student Chapter Program, EMI empowers high school and college students to launch empathy-focused clubs and projects that create measurable community impact while fostering ethical leadership and service.

Media Contact
Company Name: Empathy in Medicine Initiative (EMI)
Contact Person: Kevin Lin
Email: Send Email
City: Great Neck
State: NY
Country: United States
Website: empathyinmedicine.org

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Empathy in Medicine Initiative Launches Student Chapter Program to Advance Human-Centered Communication in Healthcare

Downtown Bellevue Dental Enhances Access to Timely Emergency Dental Services for the Community

Downtown Bellevue Dental Enhances Access to Timely Emergency Dental Services for the Community
Downtown Bellevue Dental announced a continued focus on improving access to timely and responsive dental care for individuals and families throughout the local community. The practice has expanded internal care coordination efforts to better address urgent dental needs while maintaining consistent standards across preventive and restorative services. This development reflects a broader commitment to patient-centered care and responsible clinical planning.

Located in Bellevue, WA, the practice has observed an increasing demand for prompt dental attention related to unexpected pain, injuries, and oral health concerns. In response, Downtown Bellevue Dental has refined its care processes to support efficient evaluation and treatment while maintaining a calm and professional environment. The goal remains to reduce unnecessary delays and improve patient outcomes during high-stress situations.

As part of this initiative, Downtown Bellevue Dental continues to provide structured care pathways that support Emergency Dental Care Bellevue patients rely on during urgent circumstances. These pathways prioritize clinical accuracy, clear communication, and continuity of care, ensuring patients receive appropriate guidance following emergency visits. The approach aligns with broader efforts to strengthen community access to dependable dental services.

In addition to emergency-focused improvements, the practice maintains comprehensive services led by experienced Dentist Bellevue professionals. These services emphasize prevention, patient education, and individualized treatment planning. By integrating emergency responsiveness with ongoing care, the practice supports both immediate needs and long-term oral health goals.

Downtown Bellevue Dental also remains committed to Family Dentistry Bellevue services designed to accommodate patients across all age groups. Preventive strategies, routine care, and follow-up planning are coordinated to promote consistency and trust among families seeking reliable dental support. This balanced care model reinforces the importance of accessibility and continuity in modern dental practice.

Serving Bellevue, WA, Downtown Bellevue Dental continues to align clinical operations with evolving community needs. The practice’s ongoing updates reflect a focus on responsible growth, patient safety, and service reliability.

About Downtown Bellevue Dental

Downtown Bellevue Dental provides comprehensive dental services with an emphasis on clinical excellence, patient communication, and community-centered care in Bellevue, WA.

For more information about services, community updates, and dental care resources, readers are encouraged to explore the latest news and educational materials from Downtown Bellevue Dental.

Media Contact
Company Name: Downtown Bellevue Dental
Contact Person: Sugandh Relan
Email: Send Email
Phone: (425) 454-4610
Address:410 Bellevue Way SE #302
City: Bellevue
State: WA 98004
Country: United States
Website: https://www.downtownbellevuedental.com/

U.S. Realty Associates Elevates Houston Real Estate Experience

U.S. Realty Associates Elevates Houston Real Estate Experience
U.S. Realty Associates is a professional real estate brokerage based in Houston, TX, delivering expert guidance for residential, commercial, and investment properties. With strong local market knowledge and a client-focused approach, the firm connects buyers and sellers with opportunities across Houston’s dynamic real estate landscape.

February 26, 2026 – Houston, TX – U.S. Realty Associates continues to provide expert guidance in the buying and selling of residential and commercial properties. Specializing exclusively in real estate sales, the firm offers comprehensive support for those seeking to navigate the Houston property market with confidence and efficiency.

Extensive Houston Homes for Sale

A primary focus of U.S. Realty Associates is connecting buyers with quality Houston Homes for Sale. The team leverages deep knowledge of local neighborhoods, market trends, and property values to provide detailed insights that support informed purchasing decisions. From contemporary single-family homes to luxurious estates, the firm ensures access to the most desirable properties across Houston.

Comprehensive Houston Real Estate Listings

The firm maintains accurate and up-to-date Houston Real Estate Listings, offering prospective buyers and investors a curated selection of properties tailored to various needs and investment goals. Each listing is presented with clear details on location, features, and market positioning, helping to streamline the property search process in Houston’s competitive market.

Facilitating the Decision to Buy a House in Houston

With a strong track record of assisting clients in Buying a House in Houston, U.S. Realty Associates provides professional guidance through every stage of the transaction. From identifying suitable properties to analyzing market trends, the firm’s expertise ensures that home purchases are strategic, well-informed, and aligned with investment objectives. By combining local knowledge, industry experience, and a focus on client goals, U.S. Realty Associates continues to be a trusted name for real estate transactions in Houston, TX.

Media Contact
Company Name: U.S. Realty Associates
Contact Person: Herbert Anderson
Email: Send Email
Phone: 936-234-5969
Address:1 Riverway Dr Suite #1700
City: Houston
State: Texas
Country: United States
Website: https://houstonarealistings.com/

The Prime Cleaner Opens New South Miami Location, Expanding Premium Cleaning Services Across Miami-Dade County

“Jay and Ana McGough, co-founders of The Prime Cleaner, at their new South Miami office — serving Brickell to Pinecrest with 9,000+ cleanings and 500+ five-star reviews.”
Miami’s most trusted family-owned cleaning service opens a new South Miami location at 2000 S. Dixie Hwy. Serving Brickell, Coral Gables, Coconut Grove, Pinecrest, and surrounding areas.

MIAMI, FL – The Prime Cleaner, one of Miami’s fastest-growing residential cleaning services, officially announces the opening of its new South Miami office located at 2000 South Dixie Highway, Suite 100B-A, Miami, FL 33133. The expansion marks a major milestone for the family-owned business, which has completed over 9,000 cleanings and earned 500+ five-star reviews since its founding in 2021.

The new South Miami location positions The Prime Cleaner to deliver faster response times and same-day availability to homeowners and property managers across South Miami, Coral Gables, Brickell, Coconut Grove, Pinecrest, Key Biscayne, Kendall, Palmetto Bay, Miami Beach, Edgewater, Midtown Miami, the Miami Design District, and Aventura.

A Family Business Built on Trust

Founded by Jay and his mother Ana, The Prime Cleaner was built on a straightforward belief — that every Miami homeowner deserves a cleaning team they can genuinely trust. From day one, the business has operated with background-checked professionals, non-toxic products safe for families and pets, and a consistent crew model that ensures clients see familiar faces on every visit.

“Opening our South Miami office is something we’ve been working toward for a long time. South Miami and the surrounding neighborhoods have been part of our story since the beginning. Having a physical presence here lets us serve our clients faster, respond same-day, and continue building the kind of relationships this community deserves.”— Jay McGough, Co-Founder, The Prime Cleaner

Comprehensive Cleaning Services for Miami’s Finest Homes

From the South Miami office, The Prime Cleaner offers its full suite of professional cleaning services:

  • Deep Cleaning — Top-to-bottom resets for homes that need a thorough refresh
  • Standard Recurring Cleaning — Weekly, biweekly, and monthly housekeeping plans
  • Move In / Move Out Cleaning — Built to landlord and property standards
  • Post-Construction Cleaning — Dust, debris, and construction residue removal
  • Event Cleaning — Pre and post-event cleanup for homes and venues
  • Exterior Window Cleaning — Streak-free results for interior and exterior glass
  • Tile & Grout Restoration — Deep cleaning that restores original color and shine
  • Carpet & Upholstery Cleaning — Stain removal and odor elimination safe for pets and kids
  • Post-Fumigation Cleaning — Full sanitization after pest control treatments
  • Airbnb & Short-Term Rental Cleaning — Turnover cleaning to maintain five-star ratings

Every service is backed by The Prime Cleaner’s 100% satisfaction guarantee — if a client isn’t satisfied, the team returns and corrects it at no additional charge.

Rapid Growth Driven by Five-Star Service

Since launching in 2021, The Prime Cleaner has become one of Miami’s most reviewed and most trusted residential cleaning services. With over 9,000 cleanings completed and more than 500 five-star Google reviews, the company continues to grow month over month — driven entirely by client referrals, repeat bookings, and a reputation built one home at a time.

The South Miami expansion is part of a broader growth strategy that includes new neighborhood service pages, an expanded team of background-checked cleaning professionals, and an ongoing commitment to raising the standard of residential cleaning across Miami-Dade County.

About The Prime Cleaner

The Prime Cleaner is a family-owned residential cleaning service based in Miami, Florida. Founded in 2021 by Jayger and Ana, the company specializes in deep cleaning, recurring housekeeping, move in/out cleaning, post-construction cleanup, and specialty cleaning services across Miami-Dade County. Licensed, insured, and BBB accredited, The Prime Cleaner serves homeowners, landlords, Airbnb hosts, and property managers across South Miami, Coral Gables, Brickell, Coconut Grove, Pinecrest, Key Biscayne, Kendall, Miami Beach, Edgewater, Midtown Miami, the Miami Design District, Aventura, and surrounding neighborhoods.

New South Miami Office

2000 South Dixie Highway, Suite 100B-A | Miami, FL 33133 | (786) 420-4273 | www.theprimecleaner.com/location/south-miami

Media Contact
Company Name: The Prime Cleaner
Contact Person: Jay Tomasino
Email: Send Email
Phone: (305) 575 – 2776
Address:2701 Biscayne Blvd
City: Miami
State: FL
Country: United States
Website: www.theprimecleaner.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Prime Cleaner Opens New South Miami Location, Expanding Premium Cleaning Services Across Miami-Dade County

Ophthalmoscopes Market to Reach USD 294.90 Million by 2034, Growing at 5.24% CAGR | Rising Demand for Digital and Direct Ophthalmoscopes Drives Global Expansion, analyses DelveInsight

“Ophthalmoscopes Market”
Leading ophthalmoscopes companies in the market include Baxter, HEINE Optotechnik GmbH & CO. KG, Keeler, US Ophthalmic, Rudolf Riester GmbH, Opticlar, Zumax Medical Co., Ltd., Girodmedical, Adam Rouilly Ltd., Timesco Healthcare Ltd., Zhejiang Honsun Medical Technology Co., Ltd., Iridex Corporation, NIDEK CO., Ltd., OSCAR BOSCAROL S.r.l, American Diagnostic Corporation, Lumenis Be Ltd., Veatch Ophthalmic Instruments, KIRCHNER &WILHELM GmbH + Co. KG, oDocs Eye care, Revenio Group, and others.

The global ophthalmoscopes market is poised for steady and sustained growth, projected to increase from USD 187.12 million in 2025 to USD 294.90 million by 2034, expanding at a CAGR of 5.24% during 2026–2034. The market is witnessing robust momentum due to the rising prevalence of eye disorders, growing geriatric population, technological advancements in digital ophthalmoscopes, and expanding healthcare infrastructure worldwide.

 

Unlock exclusive insights into the Ophthalmoscopes Market size, forecast, competitive landscape, and growth opportunities @ Ophthalmoscopes Market Forecast

 

Rising Prevalence of Eye Disorders Accelerates Ophthalmoscopes Market Growth

The increasing global burden of vision-related diseases such as glaucoma, diabetic retinopathy, cataracts, and age-related macular degeneration (AMD) is significantly boosting the demand for advanced ophthalmic diagnostic devices.

According to the Glaucoma Research Foundation (2025), nearly 80 million people worldwide are living with glaucoma, including around 60 million affected by open-angle glaucoma. Glaucoma is a progressive optic nerve disease that often develops without noticeable early symptoms, making routine retinal examination essential.

Similarly, cataract remains one of the most common causes of vision impairment globally. As per the London Cataract Centre (2026), an estimated 20–30 million cataract surgeries are performed annually worldwide. These procedures require comprehensive pre- and post-operative retinal assessments, further increasing the adoption of direct and indirect ophthalmoscopes in hospitals and eye clinics.

 

Technological Advancements Transforming the Ophthalmoscopes Market

Technological innovation is playing a critical role in shaping the competitive landscape of the ophthalmoscopes market. The shift from traditional optical devices to digital ophthalmoscopes, non-mydriatic systems, LED illumination models, portable handheld devices, AI-integrated imaging tools, and scanning laser ophthalmoscopes (SLO) is enhancing diagnostic accuracy and clinical efficiency.

Recent product innovations include:

  • In January 2025, Norlase received FDA 510(k) clearance and CE Mark approval for the LYNX™ pattern scanning laser indirect ophthalmoscope, the world’s first of its kind.
  • In April 2024, Haag-Streit introduced the Eyesi Indirect Ophthalmoscope ROP simulator for retinal examinations in preterm infants.
  • In April 2025, HEINE Optotechnik GmbH & Co. KG launched the BETA X Ophthalmoscope under its new X Series of handheld diagnostic instruments.

These innovations are significantly improving fundus visualization, retinal imaging, and early glaucoma detection, supporting global adoption.

 

Connect with our analysts to receive customized insights on product segments, regional trends, and competitor benchmarking @ Ophthalmoscopes Market Dynamics

 

Direct Ophthalmoscopes to Dominate Product Segment in 2025

By product type, the direct ophthalmoscopes segment is estimated to hold approximately 65% market share in 2025. Direct ophthalmoscopes are widely preferred due to:

  • Portability and ease of use
  • High magnification and upright retinal view
  • Cost-effectiveness compared to advanced imaging systems
  • Rapid clinical assessment capability

Their extensive use in hospitals, primary care settings, emergency units, and community health programs makes them a key revenue generator in the ophthalmic devices market.

Indirect ophthalmoscopes (monocular and binocular) also continue to gain traction, particularly in specialized retinal examinations and surgical settings.

 

Glaucoma Segment Leads Application Category

Among applications, the glaucoma segment is projected to account for nearly 33% of market revenue in 2025. Early detection and continuous optic nerve monitoring are crucial in preventing irreversible blindness.

The Centers for Disease Control and Prevention (2024) reported that over 3 million Americans are currently living with glaucoma, with projections reaching 6.3 million by 2050 due to population aging. This growing patient pool directly drives demand for ophthalmoscopy devices in the U.S. healthcare system.

 

Want deeper clarity on market drivers, CAGR projections, and emerging technologies? Schedule a free consultation with our healthcare market experts and make data-driven decisions with confidence – https://www.delveinsight.com/report-store/ophthalmoscopes-market

 

Hospitals and Clinics Drive End-User Demand

Hospitals and clinics remain the primary end-users in the ophthalmoscopes market due to:

  • Increasing retinal screening programs
  • Integration with electronic medical records (EMRs)
  • Rising diabetic retinopathy and glaucoma screening initiatives
  • Government-supported preventive eye care campaigns

Healthcare providers are investing heavily in digital ophthalmoscopes and portable handheld retinal diagnostic devices to improve workflow efficiency and patient outcomes.

 

North America Leads the Global Ophthalmoscopes Market

North America is expected to account for 35% of the global ophthalmoscopes market share in 2025, making it the dominant regional market.

Key growth drivers include:

  • Strong healthcare infrastructure
  • High healthcare expenditure
  • Advanced ophthalmic device manufacturing presence
  • Favorable FDA regulatory framework
  • High prevalence of glaucoma and diabetic retinopathy

The presence of leading industry players such as Baxter International, Iridex Corporation, and NIDEK CO., Ltd. further strengthens the regional market.

 

Europe and Asia-Pacific Show Strong Growth Potential

Europe’s market growth is supported by an aging population and rising glaucoma prevalence. According to the European Commission (2023), cataract surgery is the most common surgical procedure in the EU, with approximately 4.32 million operations annually.

Meanwhile, Asia-Pacific is projected to be the fastest-growing regional market due to:

  • Increasing diabetic population
  • Rising glaucoma prevalence in India and China
  • Expanding healthcare infrastructure
  • Government-supported screening initiatives

Emerging economies such as India, China, Japan, South Korea, and Australia are witnessing rapid adoption of portable and digital ophthalmoscopes.

 

Purchase the full Ophthalmoscopes Market Report now to gain a competitive advantage @ https://www.delveinsight.com/sample-request/ophthalmoscopes-market

 

Competitive Landscape of the Ophthalmoscopes Market

The global ophthalmoscopes market is moderately concentrated, with intense competition among established manufacturers and regional players. Key companies operating in the market include:

  • Baxter International
  • HEINE Optotechnik GmbH & Co. KG
  • Keeler Ltd
  • Rudolf Riester GmbH
  • Iridex Corporation
  • NIDEK CO., Ltd.
  • Revenio Group
  • Lumenis Ltd.
  • Zhejiang Honsun Medical Technology Co., Ltd.
  • Zumax Medical Co., Ltd.

 

Companies are focusing on:

  • Digital and wireless ophthalmoscopes
  • AI-powered retinal imaging
  • Mergers and acquisitions
  • Geographic expansion strategies
  • Regulatory approvals in North America and Europe

 

U.S. Tariff Impact on Ophthalmoscopes Market

U.S. tariff policies on imported medical devices have influenced pricing strategies and supply chain decisions. Increased import duties may raise procurement costs for hospitals and clinics, especially in price-sensitive segments. However, tariffs may also encourage local manufacturing and innovation within the U.S. ophthalmic device sector.

 

Ophthalmoscopes Market Segmentation Overview

The Ophthalmoscopes Market is segmented by:

Product Type

  • Direct Ophthalmoscopes
  • Indirect Ophthalmoscopes (Monocular & Binocular)

Application

  • Glaucoma
  • Retinal Disease
  • Diabetes Eye Disease
  • Others

End-Users

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Geography

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

 

For detailed market insights, competitive analysis, regional forecasts, and strategic opportunities in the global ophthalmoscopes market, access the full report @ Ophthalmoscopes Competitive Landscape

 

Ophthalmoscopes Market Outlook 2026–2034

The global ophthalmoscopes market is expected to maintain steady growth due to:

  • Rising burden of glaucoma and diabetic retinopathy
  • Increasing geriatric population
  • Expansion of preventive eye care programs
  • Digital transformation in ophthalmic diagnostics
  • Strong R&D investments by leading manufacturers

With growing awareness about early vision screening and retinal health monitoring, the demand for advanced digital ophthalmoscopes, portable handheld devices, and AI-integrated retinal imaging systems is set to accelerate significantly through 2034.

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ophthalmoscopes Market to Reach USD 294.90 Million by 2034, Growing at 5.24% CAGR | Rising Demand for Digital and Direct Ophthalmoscopes Drives Global Expansion, analyses DelveInsight

RINVOQ Market Growth Accelerates Across IBD, Dermatology, and Rheumatology as Global Sales Momentum Strengthens | DelveInsight

“RINVOQ Market”
The global immunology market is witnessing a significant transformation as RINVOQ (upadacitinib) continues to demonstrate strong prescription growth, expanding indications, and robust revenue performance.

DelveInsight’s “RINVOQ Sales Forecast, and Market Size Analysis – 2034” report provides comprehensive insights of RINVOQ for approved indications like Ankylosing Spondylitis, Atopic Dermatitis, Axial SpA, Crohn’s Disease, Giant Cell Arteritis, Psoriatic Arthritis, Rheumatoid Arthritis, and Ulcerative Colitis; as well as potential indications like Alopecia Areata, Hidradenitis Suppurativa, Systemic Lupus Erythematosus (SLE), Takayasu Arteritis, and Vitiligo in the 7MM.

According to insights by DelveInsight, RINVOQ is rapidly emerging as a leading oral JAK inhibitor across multiple autoimmune and inflammatory diseases, positioning itself as a key growth driver in AbbVie’s immunology portfolio.

 

Download the Complete RINVOQ Sales Forecast Report (2020–2034) to access detailed revenue projections, peak sales estimates, and competitive intelligence across the 7MM @ RINVOQ Market Forecast

 

Key Factors Driving RINVOQ Market Growth

1. Rising Market Share and Surge in New Patient Starts

RINVOQ is steadily gaining market share across major autoimmune disease segments, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, and Crohn’s disease.

A marked increase in new patient starts has fueled prescription growth, supported by strong physician confidence and strategic commercial initiatives led by AbbVie. Focused physician education programs and expanded market access strategies are further strengthening adoption rates across the United States, Europe, and Japan.

 

2. Expansion Across Key Indications

Inflammatory Bowel Disease (IBD): RINVOQ is gaining substantial traction in ulcerative colitis and Crohn’s disease, backed by favorable clinical trial data and growing real-world evidence (RWE). IBD continues to be a primary revenue contributor, with strong volume momentum observed across major markets.

Atopic Dermatitis: In the moderate-to-severe atopic dermatitis segment, RINVOQ has emerged as one of the leading oral treatment options, offering convenience over injectable biologics and driving improved patient adherence.

Spondyloarthritis and Psoriatic Arthritis: The therapy is increasingly preferred in axial spondyloarthritis and psoriatic arthritis due to its oral small-molecule profile and competitive efficacy outcomes, providing an attractive alternative to TNF inhibitors and other biologics.

Pipeline developments further indicate potential label expansions in alopecia areata, hidradenitis suppurativa, systemic lupus erythematosus (SLE), Takayasu arteritis, and vitiligo, which are expected to broaden the RINVOQ market size through 2034.

 

3. Geographic Expansion Driving Global Uptake

RINVOQ continues to expand into both developed and emerging markets. The Asia-Pacific region is projected to experience the fastest growth, driven by rising autoimmune disease prevalence, expanding healthcare infrastructure, and improved awareness of advanced targeted therapies.

AbbVie’s strengthened local partnerships and distribution networks are accelerating RINVOQ uptake across Europe and Japan, reinforcing its global commercial footprint.

 

4. New Indication Approvals Enhancing Competitive Position

Regulatory approvals are significantly expanding RINVOQ’s treatment landscape.

In April 2025, the European Commission granted marketing authorization to RINVOQ (15 mg once daily) for the treatment of giant cell arteritis (GCA) in adult patients, making it the first and only oral JAK inhibitor approved in the EU for this condition.

In the United States, RINVOQ is approved for pediatric patients aged two years and older with polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic arthritis (PsA) who have had inadequate responses to TNF blockers. The launch of a weight-based oral solution, RINVOQ LQ, further expands its pediatric rheumatology portfolio.

 

5. Strong IBD Volume Momentum

IBD remains a cornerstone growth segment for RINVOQ. Updated 2025 insights highlight sustained prescription gains in ulcerative colitis and Crohn’s disease markets, driven by superior efficacy data and increasing reliance on real-world evidence.

Growing payer confidence, combined with value-based care models, is further supporting long-term market penetration.

 

Request a Free Sample Copy of the RINVOQ Market Analysis and explore in-depth insights on pricing trends, regulatory milestones, and pipeline expansion. @ RINVOQ Sales and Cost Analysis

 

Recent RINVOQ Developments Strengthening Market Position

In July 2025, AbbVie announced positive topline results from the Phase III UP-AA program evaluating RINVOQ (15 mg and 30 mg once daily) in patients with severe alopecia areata. The study demonstrated promising efficacy in a population with significant scalp hair loss.

RINVOQ is currently in Phase III clinical development for multiple high-value indications, including:

  • Alopecia areata
  • Hidradenitis suppurativa
  • Systemic lupus erythematosus
  • Takayasu arteritis
  • Vitiligo

These late-stage developments are expected to substantially increase RINVOQ peak sales potential in the seven major markets (7MM).

 

RINVOQ Sales Performance and Revenue Outlook

RINVOQ’s global revenue reached approximately USD 6 billion in 2024, underscoring its rapid commercial success.

The “RINVOQ Sales Forecast and Market Size Analysis – 2034” report by DelveInsight provides:

  • Current and forecasted RINVOQ sales across the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan
  • Market size projections through 2034
  • SWOT analysis and competitive intelligence
  • Pricing and reimbursement landscape
  • Patent and generic entry assessment
  • Regulatory milestones and expected launch timelines

With increasing adoption across immunology segments, analysts anticipate continued double-digit growth momentum in the near term.

 

Unlock RINVOQ Competitive Landscape Insights Today – Analyze emerging therapies, SWOT analysis, and market positioning strategies shaping the immunology space @ RINVOQ Competitive Landscape Insights

 

RINVOQ Mechanism of Action and Clinical Differentiation

RINVOQ is a selective JAK inhibitor targeting JAK1-mediated pathways. In human leukocyte cellular assays, it demonstrated potent inhibition of cytokine-induced STAT phosphorylation mediated by JAK1 and JAK1/JAK3 pathways.

Its oral small-molecule profile offers:

  • Improved patient convenience compared to injectable biologics
  • Strong efficacy across multiple inflammatory pathways
  • Favorable safety and tolerability data
  • Broad applicability in immune-mediated inflammatory diseases

These attributes contribute to RINVOQ’s differentiation in an increasingly competitive immunology market.

 

Do you know your drug’s competitive positioning against RINVOQ? RINVOQ Drugs Insights

 

RINVOQ Competitive Landscape and Market Trends

The immunology market is evolving toward:

  • Personalized medicine and biomarker-driven therapies
  • Real-world evidence integration
  • Value-based pricing and reimbursement frameworks
  • Increased competition from late-stage emerging biologics and small molecules

Despite competitive pressures, RINVOQ’s expanding label, broad clinical development program, and strong commercial execution position it as a major growth engine for AbbVie’s post-HUMIRA portfolio strategy.

 

Connect with Our Analysts for Customized RINVOQ Market Insights and receive tailored forecasts, indication-specific analysis, and strategic guidance for informed decision-making – https://www.delveinsight.com/sample-request/rinvoq-market-drug-insight-and-market-forecast

 

RINVOQ Market Outlook Through 2034

The future RINVOQ market scenario is expected to be shaped by:

  • Continued new patient growth
  • Broader uptake in dermatology, rheumatology, and gastroenterology
  • Regulatory approvals in new high-prevalence indications
  • Geographic expansion in Asia-Pacific and emerging markets
  • Strong IBD prescription momentum

As late-stage pipeline therapies approach launch, competitive intensity will increase; however, RINVOQ’s diversified indication portfolio and clinical differentiation are expected to sustain long-term revenue expansion.

 

About DelveInsight

DelveInsight is a leading healthcare market research and consulting firm providing actionable market intelligence across pharmaceuticals, biotechnology, and medical devices. Through in-depth drug insights, competitive intelligence, and long-term sales forecasts, DelveInsight supports strategic decision-making for global life sciences stakeholders.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: RINVOQ Market Growth Accelerates Across IBD, Dermatology, and Rheumatology as Global Sales Momentum Strengthens | DelveInsight